TLSI Q2 2025 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$11M+52.3% YoY

Gross Profit

$9M83.9% margin

Operating Income

-$7M-65.4% margin

Net Income

-$8M-73.9% margin

EPS (Diluted)

$-0.27

QoQ Revenue Growth

+22.3%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$41M

Total Liabilities

$61M

Stockholders' Equity

-$19M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$7M	+52.3%
Gross Profit	$9M	$6M	+45.9%
Operating Income	-$7M	-$8M	+10.3%
Net Income	-$8M	-$4M	-91.3%